Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what information his Department holds on regional variations in (a) the speed of diagnosis and (b) health outcomes for blood cancer patients.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out.
The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer.
Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.
Professor Lord Darzi has undertaken an independent investigation into the state of the NHS, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will therefore set out any further priorities on cancer and health in due course.
The National Disease Registration Service, through the National Cancer Registration and Analysis Services (NCRAS), collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The National Disease Registration Service’s website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://www.cancerdata.nhs.uk/
All cases of cancer diagnosed and treated in the NHS in England are registered by the NCRAS. This creates a clinically rich data resource that is used to measure diagnosis, treatment, and outcomes for patients diagnosed with cancer. The data held by the NCRAS supports service provision and commissioning in the NHS, clinical audits, and public health and epidemiological research, all of which contribute to improved outcomes for those diagnosed with cancer.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to improve the (a) speed and (b) accuracy of blood cancer diagnoses.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out.
The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer.
Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.
Professor Lord Darzi has undertaken an independent investigation into the state of the NHS, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will therefore set out any further priorities on cancer and health in due course.
The National Disease Registration Service, through the National Cancer Registration and Analysis Services (NCRAS), collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The National Disease Registration Service’s website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://www.cancerdata.nhs.uk/
All cases of cancer diagnosed and treated in the NHS in England are registered by the NCRAS. This creates a clinically rich data resource that is used to measure diagnosis, treatment, and outcomes for patients diagnosed with cancer. The data held by the NCRAS supports service provision and commissioning in the NHS, clinical audits, and public health and epidemiological research, all of which contribute to improved outcomes for those diagnosed with cancer.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the survival rate of blood cancer patients.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
We will get the National Health Service diagnosing cancer earlier and treating it faster, including blood cancer. This is supported by NHS England’s key ambition on cancer, to meet the Faster Diagnosis Standard, which sets a target of 28 days from urgent referral by a general practitioner or screening programme to patients being told that they have cancer, or that cancer is ruled out.
The Department is committed to implementing the recommendations of Lord O'Shaughnessy’s review into commercial clinical trials, making sure that the United Kingdom leads the world in clinical trials, and ensuring that innovative, lifesaving treatments are accessible to NHS patients, including those with blood cancer.
Making improvements across different cancer types is critical to reducing disparities in cancer survival. Early cancer diagnosis is also a specific priority within the NHS’s wider Core20Plus5 approach to reducing healthcare inequalities.
Professor Lord Darzi has undertaken an independent investigation into the state of the NHS, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will therefore set out any further priorities on cancer and health in due course.
The National Disease Registration Service, through the National Cancer Registration and Analysis Services (NCRAS), collects information on how many people in England have cancer. Blood cancer is included as a distinct category, labelled haematological neoplasms. The National Disease Registration Service’s website also shows the number of people treated for different tumour types by treatment type, as well as survival rates, mortality rates, and data on urgent suspected cancer referrals. Further information is available at the following link:
https://www.cancerdata.nhs.uk/
All cases of cancer diagnosed and treated in the NHS in England are registered by the NCRAS. This creates a clinically rich data resource that is used to measure diagnosis, treatment, and outcomes for patients diagnosed with cancer. The data held by the NCRAS supports service provision and commissioning in the NHS, clinical audits, and public health and epidemiological research, all of which contribute to improved outcomes for those diagnosed with cancer.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he is taking to help improve outcomes for skin cancer patients.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
To improve outcomes for skin cancer patients, NHS England is undertaking a number of interventions. This includes funding and programme management to support local cancer alliances in achieving the Faster Diagnosis Standard for skin cancer. NHS England provides implementation guidance, as well as collaboration and networking events, to support providers with ways to deliver best practice timed pathways.
Since 2023/24, NHS England has also been rolling out teledermatology services, which allow a virtual review of dermoscopic images. In providers where this has been fully implemented, improvements in workforce capacity have been seen doubling the number of patients that can be reviewed per clinic in some cases, and improving Faster Diagnosis Standard performance. Nationally, as of June 2024, 43% of all urgent suspected skin cancer referrals were managed via teledermatology, with the aim of reaching 50% by the end of the financial year.
Asked by: Satvir Kaur (Labour - Southampton Test)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether he has made an assessment of the potential merits of introducing legislation to require all vaping products to be (a) sold in plain packaging and (b) kept out of sight behind the counter.
Answered by Andrew Gwynne
As set out in the Kings Speech, the Government will soon introduce legislation which will impose limits on the sale and marketing of vapes, and stop future generations from becoming hooked on nicotine.
The Tobacco and Vapes Bill will give ministers’ powers to regulate the flavours, packaging, and point of sale display of vapes. Further consultation and assessment will follow which will determine what specific regulations are brought in using these powers.